Prolonged SARS-CoV-2 Risk Varies Across Immunosuppressive Conditions

Medically reviewed by Judith Stewart, BPharm. Last updated on Jan 31, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 31, 2024 -- The risk for prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies across immunosuppressive conditions, according to a study published in the Jan. 24 issue of Science Translational Medicine.

Yijia Li, M.D., from Harvard Medical School in Boston, and colleagues performed a detailed viro-immunologic analysis of a prospective cohort of patients with COVID-19 to examine the immune defects that predispose an individual to persistent COVID-19.

The researchers found that in individuals with severe immunosuppression due to hematologic malignancy or transplant (S-HT), the median times to nasal viral RNA and culture clearance were 72 and 40 days, respectively, which were significantly longer than clearance rates for patients with severe immunosuppression due to autoimmunity or B cell deficiency (S-A), those with nonsevere immunodeficiency, and those who were not immunocompromised. Greater SARS-CoV-2 evolution and a higher risk for developing resistance against therapeutic monoclonal antibodies were seen in severely immunocompromised individuals. Diminished SARS-CoV-2-specific humoral responses were seen for S-HT and S-A patients, while reduced T-cell mediated responses were only seen in the S-HT group.

"Our results highlight the finding that the risk of chronic SARS-CoV-2 infection is not uniform across immunosuppressive conditions and provide clarity on which immunosuppression conditions predispose individuals to delayed SARS-CoV-2 RNA and culture clearance as well as viral evolution," the authors write.

Several authors disclosed ties to the pharmaceutical and medical technology industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords